Fintel on MSN2d
RBC Capital Initiates Coverage of Natera (NTRA) with Outperform Recommendation
Fintel reports that on March 13, 2025, RBC Capital initiated coverage of Natera (NasdaqGS:NTRA) with a Outperform ...
RBC Capital Sticks to Their Hold Rating for B2Gold (BTG)
In a report released yesterday, Michael Siperco from RBC Capital maintained a Hold rating on B2Gold (BTG – Research Report), with a price ...
Wells Fargo’s stock dips even as analyst proclaims ‘good entry point’ for investors
RBC Capital says Wells Fargo’s stock is a good buy after the recent financial-stock selloff — but its continued to fall along ...
Basic Materials Roundup: Market Talk
Find insight on Radius Recycling, base metal prices, the Australian mining sector and more in the latest Market Talks ...
Neurocrine price target lowered to $139 from $148 at RBC Capital
RBC Capital lowered the firm’s price target on Neurocrine (NBIX) to $139 from $148 and keeps a Sector Perform rating on the shares. The payer ...
Yahoo Finance8d
Canadian Natural price target raised to C$63 from C$62 at RBC Capital
RBC Capital raised the firm’s price target on Canadian Natural (CNQ) to C$63 from C$62 and keeps an Outperform rating on the shares. The firm’s bullish stance towards the company reflects its ...
RBC bumps Wells Fargo’s rating to ’outperform’ after stock decline
Once the asset cap is removed, Well Fargo would be able to execute its growth strategy and reach its 15% return on tangible equity target. Shares of Wells Fargo have declined in recent weeks, but RBC ...
U.S. Bancorp (USB) RBC Capital Markets Global Financial Institutions Conference (Transcript)
RBC Capital Markets Global Financial Institutions Conference Transcript March 5, 2025 11:20 AM ETCompany ParticipantsJohn Stern ...
JD Supra4d
NAIC Establishes the Risk-Based Capital Model Governance (EX) Task Force in 2025
One of the stated four 2025 NAIC initiatives [1] is: ...
Galderma downgraded by RBC Capital Markets on H2 risks, limited upside potential
Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...
RBC Capital Remains a Buy on O-I Glass (OI)
RBC Capital analyst Arun Viswanathan maintained a Buy rating on O-I Glass (OI – Research Report) yesterday and set a price target of $16.00.